about
PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancerRole of platelet-derived growth factors in physiology and medicineHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverMechanisms of hepatic fibrogenesisPlatelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function.Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C.Hepatic fibrosis.Molecular mechanisms of liver fibrosis in HIV/HCV coinfectionEmerging roles of PDGF-D signaling pathway in tumor development and progression.Targeting the PDGF signaling pathway in the treatment of non-malignant diseases.Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.Hepatic stellate cells: central modulators of hepatic carcinogenesis.Understanding the mechanism of hepatic fibrosis and potential therapeutic approachesM1 Muscarinic Receptor Deficiency Attenuates Azoxymethane-Induced Chronic Liver Injury in Mice.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?Ethyl Acetate Fraction of Amomum xanthioides Exerts Antihepatofibrotic Actions via the Regulation of Fibrogenic Cytokines in a Dimethylnitrosamine-Induced Rat Model.Advances in antifibrotic therapy.Experimental mouse models for hepatocellular carcinoma research.Differential tumorigenic potential and matriptase activation between PDGF B versus PDGF D in prostate cancer.Hepatobiliary quiz-3 (2012)Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis.Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.Epithelial-mesenchymal interactions in biliary diseasesFactor VII activating protease (FSAP): a novel protective factor in liver fibrosis.Pathogenesis of liver cirrhosis.Pathophysiology of portal hypertension and its clinical links.miR‑203 inhibits the expression of collagen‑related genes and the proliferation of hepatic stellate cells through a SMAD3‑dependent mechanism.Gastric cancer-derived MSC-secreted PDGF-DD promotes gastric cancer progression.Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo.Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma.CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.Platelet-derived growth factor involvement in myocardial remodeling following infarction.Anti-fibrotic effects of the Masson pine pollen aqueous extract on hepatic fibrosis rat model.Role of liver ICAM-1 in metastasis.Cell-Based Therapies for Tissue Fibrosis.Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury.Rosiglitazone inhibits TGF-β 1 induced activation of human Tenon fibroblasts via p38 signal pathway.CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis.
P2860
Q28085644-DC928DFF-25F1-411B-83E1-161A51C205A0Q29615222-970E9E05-9040-45FF-8608-D21F7C73A242Q29616840-DD3964C9-18F3-41CA-AAF6-F5648C442114Q29619336-30D807D5-C019-4CD0-AD75-D2745F9F2AABQ30485959-DF65EFD0-A241-46F8-A4CA-0834550C501DQ33402906-CBF3C32F-287E-406C-A54A-0050FD938787Q33904174-49D7D9BA-6EDD-4F4A-AE9B-D4DE53B48BDCQ33907429-5992EF72-BFD6-4529-A56E-28D817EC16BCQ33912608-F6D87E59-3EEA-4DD0-9554-56EBC0D8683CQ34352802-0253E558-E06D-43DA-B8B8-25CD81030DB5Q34992341-B6F011CC-A68D-46D2-A4B9-A201260BF2E7Q35642468-64771572-6117-4572-8679-A10B891EE963Q36020916-AB405683-BC43-4282-8A30-A84D6FDF9BDEQ36064546-97D4E5F2-2E00-4950-8386-A5ED7C6A89E1Q36672445-3B611207-567F-457E-AC35-EE62294723DFQ36924390-F3EBC920-FC97-4E47-BC6D-90A58FDE9CD7Q37198484-5D7727EF-4CFD-40CC-B158-F2A075852BFEQ37353099-8C6663A9-E99A-4E48-A149-17988B9968A5Q37574072-E9A2C357-9EDB-4766-8C76-148DCD65AF71Q37593021-61C37BE6-9F50-4633-AB28-B89A3CB3F314Q37613918-0D689C63-2E2E-480B-9F13-E7A88E4ABE97Q37681790-D948F936-1E63-4BB7-9446-DF76A08E1999Q37801658-8D40CD3C-B5FF-48E1-8350-FEFB9CB2D1ACQ37846143-3F174A09-E23F-4945-88D5-F064394A552BQ38185361-F70CBFE9-361A-4C10-B3CB-820F2199278DQ38223369-8EE5A510-EB35-4CC9-81B4-84898883F0CBQ38371453-50550FD9-D3B4-4B96-8B05-77598DCDF6FEQ38701154-5AD953A8-6622-496F-8518-5DB9B4912021Q38983836-1EBC487F-E805-432E-9652-133597CAFF5EQ39179249-3FC6135B-31FC-498A-B8FB-D29A10281104Q39291844-5B1D128F-8838-4B56-B4B5-DDE7241ADE00Q39506866-EEF506FB-5E86-4836-B22F-62C5D284F496Q39508427-1CE8E5D6-F7B7-45FB-AB7B-3A09D147395FQ39903545-C44F056A-88B8-48AA-B224-DF3F697BD068Q41642089-0CA2C094-A7D6-4B75-82E1-92648EC41457Q41701847-5AB571F0-A6DC-4DCF-9504-B764692EA400Q42369905-EBD9E2B4-4F08-4079-BE7A-0D69EFFB9969Q42439505-6B29A324-BF68-4FFB-87A3-FE41A0CCD4D3Q42829908-4A969DA2-2894-4472-8044-CA5231BFCFCBQ43159403-E51126F8-05AA-4D69-993A-41BAB4A35D35
P2860
description
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Juni 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/06/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/06/01)
@nl
наукова стаття, опублікована в червні 2007
@uk
مقالة علمية (نشرت في يونيو 2007)
@ar
name
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@ast
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@en
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@nl
type
label
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@ast
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@en
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@nl
prefLabel
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@ast
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@en
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@nl
P2093
P3181
P1476
Pro-fibrogenic potential of PDGF-D in liver fibrosis
@en
P2093
Axel M. Gressner
Claudia R. C. van Roeyen
Erawan Borkham-Kamphorst
Jürgen Floege
Tammo Ostendorf
P304
P3181
P356
10.1016/J.JHEP.2007.01.029
P577
2007-06-01T00:00:00Z